Daniela Probst-Mihic

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.

The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.

Journal: Human pathology

Published: February 10, 2026

Spatially-resolved single-cell imaging of melanoma brain metastases identifies localized immune patterns predictive of immune checkpoint blockade response.

Spatially-resolved single-cell imaging of melanoma brain metastases identifies localized immune patterns predictive of immune checkpoint blockade response.

Journal: Neuro-oncology

Published: January 20, 2026

Doughnut-shaped bone lesions on 18F-FDG-PET/CT may indicate pseudoprogression under immuno(radio)therapy.

Doughnut-shaped bone lesions on 18F-FDG-PET/CT may indicate pseudoprogression under immuno(radio)therapy.

Journal: Annals of nuclear medicine

Published: December 10, 2025

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Journal: Cancers

Published: November 16, 2025

An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).

An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 06, 2025

The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

Journal: Swiss medical weekly

Published: August 14, 2025

The chromatin guardian ATRX is a strong prognostic biomarker in melanoma.

The chromatin guardian ATRX is a strong prognostic biomarker in melanoma.

Journal: Scientific reports

Published: May 21, 2025

The Impact of Next-Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic Neoplasms.

The Impact of Next-Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic Neoplasms.

Journal: Journal of cutaneous pathology

Published: May 17, 2025

Immunotherapy response and resistance in patients with advanced uveal melanoma: a retrospective cohort study.

Immunotherapy response and resistance in patients with advanced uveal melanoma: a retrospective cohort study.

Journal: Clinical and experimental medicine

Published: June 03, 2024

Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5.

Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5.

Journal: Journal of cutaneous pathology

Published: May 07, 2024

A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled Ophtioles.

A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled Ophtioles.

Journal: Klinische Monatsblatter fur Augenheilkunde

Published: April 23, 2024

The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic Neoplasms.

The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic Neoplasms.

Journal: The American journal of surgical pathology

Published: April 09, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026